These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 15879881

  • 1. Activation of natural killer T cells by alpha-galactosylceramide mediates clearance of bacteria in murine urinary tract infection.
    Minagawa S, Ohyama C, Hatakeyama S, Tsuchiya N, Kato T, Habuchi T.
    J Urol; 2005 Jun; 173(6):2171-4. PubMed ID: 15879881
    [Abstract] [Full Text] [Related]

  • 2. Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy.
    Nakashima H, Inui T, Habu Y, Kinoshita M, Nagao S, Kawaguchi A, Miura S, Shinomiya N, Yagita H, Seki S.
    Gastroenterology; 2006 Nov; 131(5):1573-83. PubMed ID: 17064698
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hyporesponsiveness to natural killer T-cell ligand alpha-galactosylceramide in cancer-bearing state mediated by CD11b+ Gr-1+ cells producing nitric oxide.
    Yanagisawa K, Exley MA, Jiang X, Ohkochi N, Taniguchi M, Seino K.
    Cancer Res; 2006 Dec 01; 66(23):11441-6. PubMed ID: 17145891
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Activation of invariant NK T cells protects against experimental rheumatoid arthritis by an IL-10-dependent pathway.
    Miellot A, Zhu R, Diem S, Boissier MC, Herbelin A, Bessis N.
    Eur J Immunol; 2005 Dec 01; 35(12):3704-13. PubMed ID: 16304639
    [Abstract] [Full Text] [Related]

  • 8. Activation-induced NKT cell hyporesponsiveness protects from alpha-galactosylceramide hepatitis and is independent of active transregulatory factors.
    Biburger M, Tiegs G.
    J Leukoc Biol; 2008 Jul 01; 84(1):264-79. PubMed ID: 18407967
    [Abstract] [Full Text] [Related]

  • 9. Decreased expressions of CD1d molecule on liver dendritic cells in subcutaneous tumor bearing mice.
    Tatsumi T, Takehara T, Yamaguchi S, Sasakawa A, Yamamoto M, Fujita Y, Miyagi T, Ohkawa K, Hayashi N.
    J Hepatol; 2008 Nov 01; 49(5):779-86. PubMed ID: 18760855
    [Abstract] [Full Text] [Related]

  • 10. Innate Valpha14(+) natural killer T cells mature dendritic cells, leading to strong adaptive immunity.
    Fujii S, Shimizu K, Hemmi H, Steinman RM.
    Immunol Rev; 2007 Dec 01; 220():183-98. PubMed ID: 17979847
    [Abstract] [Full Text] [Related]

  • 11. Production of both IL-27 and IFN-gamma after the treatment with a ligand for invariant NK T cells is responsible for the suppression of Th2 response and allergic inflammation in a mouse experimental asthma model.
    Fujita H, Teng A, Nozawa R, Takamoto-Matsui Y, Katagiri-Matsumura H, Ikezawa Z, Ishii Y.
    J Immunol; 2009 Jul 01; 183(1):254-60. PubMed ID: 19542437
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. CD1d-dependent macrophage-mediated clearance of Pseudomonas aeruginosa from lung.
    Nieuwenhuis EE, Matsumoto T, Exley M, Schleipman RA, Glickman J, Bailey DT, Corazza N, Colgan SP, Onderdonk AB, Blumberg RS.
    Nat Med; 2002 Jun 01; 8(6):588-93. PubMed ID: 12042809
    [Abstract] [Full Text] [Related]

  • 14. IL-21 enhances dendritic cell ability to induce interferon-gamma production by natural killer T cells.
    Maeda M, Yanagawa Y, Iwabuchi K, Minami K, Nakamaru Y, Takagi D, Fukuda S, Onoé K.
    Immunobiology; 2007 Jun 01; 212(7):537-47. PubMed ID: 17678711
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevention of injury-induced suppression of T-cell immunity by the CD1d/NKT cell-specific ligand alpha-galactosylceramide.
    Tulley JM, Palmer JL, Gamelli RL, Faunce DE.
    Shock; 2008 Feb 01; 29(2):269-77. PubMed ID: 17693934
    [Abstract] [Full Text] [Related]

  • 17. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
    Minagawa M, Iiai T, Sato Y, Yamamoto S, Hatakeyama K.
    Gan To Kagaku Ryoho; 2005 Oct 01; 32(11):1553-5. PubMed ID: 16315866
    [Abstract] [Full Text] [Related]

  • 18. Modulation of murine experimental allergic conjunctivitis by treatment with alpha-galactosylceramide.
    Fukushima A, Sumi T, Fukuda K, Yamaguchi T, Kumagai N, Nishida T, Ueno H.
    Immunol Lett; 2006 Sep 15; 107(1):32-40. PubMed ID: 16930723
    [Abstract] [Full Text] [Related]

  • 19. Co-inhibitory roles for glucocorticoid-induced TNF receptor in CD1d-dependent natural killer T cells.
    Chen S, Ndhlovu LC, Takahashi T, Takeda K, Ikarashi Y, Kikuchi T, Murata K, Pandolfi PP, Riccardi C, Ono M, Sugamura K, Ishii N.
    Eur J Immunol; 2008 Aug 15; 38(8):2229-40. PubMed ID: 18624295
    [Abstract] [Full Text] [Related]

  • 20. Protective role of α-galactosylceramide-stimulated natural killer T cells in genital tract infection with Chlamydia muridarum.
    Wang H, Zhao L, Peng Y, Liu J, Qi M, Chen Q, Yang X, Zhao W.
    FEMS Immunol Med Microbiol; 2012 Jun 15; 65(1):43-54. PubMed ID: 22309187
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.